Shandong Weigao Group Medical Polymer Company Limited reported that, as of the end of February 2026, the total authorised share capital remained at 4.52 billion H shares and 48.30 million non-listed shares, bringing the aggregate authorised capital to RMB457.06 million.
The total issued share count stood at 4.52 billion, unchanged from the previous month. Among these, 4.48 billion shares were in circulation, while treasury shares rose to 41.58 million. A net 1.46 million shares were repurchased during February at prices between HKD4.99 and HKD5.33, resulting in a corresponding increase in treasury shares. The public float requirement was confirmed to be in compliance with relevant regulations.
Comments